Pfizer reported quarterly EPS of $0.75, beating the Zacks Consensus Estimate of $0.71 by $0.04, or about 5.6%. However, earnings were down from $0.92 per share a year ago, indicating weaker year-over-year profitability. The print is a modest positive for the stock, but the article provides no guidance or revenue detail.
Pfizer reported quarterly EPS of $0.75, beating the Zacks Consensus Estimate of $0.71 by $0.04, or about 5.6%. However, earnings were down from $0.92 per share a year ago, indicating weaker year-over-year profitability. The print is a modest positive for the stock, but the article provides no guidance or revenue detail.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
